Anna Perdrix Rosell
About Anna Perdrix Rosell
Dr. Anna Perdrix Rosell is a distinguished cancer researcher and entrepreneur, recognized for her contributions to science and healthcare, including her inclusion in Forbes' 30 under 30 list in 2018.
Dr Anna Perdrix Rosell Company
Dr. Anna Perdrix Rosell is the Co-CEO and Founder of an influential organization in the field of cancer research and biotechnology. Under her leadership, the company focuses on innovative approaches in cancer treatment and translational medicine. Her role includes overseeing strategic initiatives, business operations, and driving forward the company’s mission to transform cancer care through research and development.
Dr Anna Perdrix Rosell Education and Expertise
Dr. Anna Perdrix Rosell has a robust educational background in cancer research and business management. She earned an MRes in Translational Cancer Medicine from King's College London and completed a PhD in Cancer Research at the Francis Crick Institute in London. In addition, she holds an MBA, which complements her scientific expertise with business acumen. Her extensive education allows her to bridge the gap between groundbreaking research and its practical applications in the healthcare industry.
Dr Anna Perdrix Rosell Scientific Contributions
Dr. Anna Perdrix Rosell’s scientific contributions are well-recognized in the academic community. She has published her research in prestigious journals such as Current Biology, Cell, and Nature Medicine. Her work has significantly advanced the understanding of cancer biology and translational medicine, leading to multiple patent applications. These publications attest to her role as a leader in cancer research and her dedication to scientific innovation.
Dr Anna Perdrix Rosell Collaborative Projects
Dr. Anna Perdrix Rosell has been the principal investigator in more than 15 large international collaborative projects. These projects have spanned various aspects of cancer research and biotechnology, involving partnerships with researchers, industry leaders, and institutions globally. Her role in these collaborations underscores her ability to lead complex, multidisciplinary teams and her contributions to advancing global cancer research initiatives.
Dr Anna Perdrix Rosell Awards and Recognitions
In 2018, Dr. Anna Perdrix Rosell was recognized by Forbes on the 30 under 30 list in the Science and Healthcare category. This accolade highlights her significant impact within the scientific community at a relatively young age. Additionally, she is a member of the UK’s Bioindustry Association Engineering Biology and Science and Innovation Advisory Committees, further demonstrating her influence and thought leadership in the fields of biotechnology and cancer research.